rs398124645
Variant names:
Variant summary
Our verdict is Uncertain significance. The variant received 5 ACMG points: 5P and 0B. PM2PP3_ModeratePP5
The NM_003184.4(TAF2):c.1945T>C(p.Trp649Arg) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.00000137 in 1,461,860 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Pathogenic (no stars).
Frequency
Genomes: not found (cov: 33)
Exomes 𝑓: 0.0000014 ( 0 hom. )
Consequence
TAF2
NM_003184.4 missense
NM_003184.4 missense
Scores
13
5
1
Clinical Significance
Conservation
PhyloP100: 7.46
Publications
2 publications found
Genes affected
TAF2 (HGNC:11536): (TATA-box binding protein associated factor 2) Initiation of transcription by RNA polymerase II requires the activities of more than 70 polypeptides. The protein that coordinates these activities is transcription factor IID (TFIID), which binds to the core promoter to position the polymerase properly, serves as the scaffold for assembly of the remainder of the transcription complex, and acts as a channel for regulatory signals. TFIID is composed of the TATA-binding protein (TBP) and a group of evolutionarily conserved proteins known as TBP-associated factors or TAFs. TAFs may participate in basal transcription, serve as coactivators, function in promoter recognition or modify general transcription factors (GTFs) to facilitate complex assembly and transcription initiation. This gene encodes one of the larger subunits of TFIID that is stably associated with the TFIID complex. It contributes to interactions at and downstream of the transcription initiation site, interactions that help determine transcription complex response to activators. [provided by RefSeq, Jul 2008]
TAF2 Gene-Disease associations (from GenCC):
- microcephaly-thin corpus callosum-intellectual disability syndromeInheritance: AR Classification: STRONG, MODERATE, SUPPORTIVE, LIMITED Submitted by: G2P, Orphanet, Labcorp Genetics (formerly Invitae), Ambry Genetics
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Uncertain_significance. The variant received 5 ACMG points.
PM2
Very rare variant in population databases, with high coverage;
PP3
MetaRNN computational evidence supports a deleterious effect, 0.938
PP5
Variant 8-119783548-A-G is Pathogenic according to our data. Variant chr8-119783548-A-G is described in ClinVar as Pathogenic. ClinVar VariationId is 92249.Status of the report is no_assertion_criteria_provided, 0 stars.
Transcripts
RefSeq
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| TAF2 | ENST00000378164.7 | c.1945T>C | p.Trp649Arg | missense_variant | Exon 16 of 26 | 1 | NM_003184.4 | ENSP00000367406.2 | ||
| TAF2 | ENST00000686879.1 | c.1945T>C | p.Trp649Arg | missense_variant | Exon 16 of 27 | ENSP00000509206.1 | ||||
| TAF2 | ENST00000685235.1 | c.1945T>C | p.Trp649Arg | missense_variant | Exon 16 of 26 | ENSP00000510174.1 | ||||
| TAF2 | ENST00000688645.1 | c.1945T>C | p.Trp649Arg | missense_variant | Exon 16 of 25 | ENSP00000509978.1 | ||||
| TAF2 | ENST00000523904.2 | c.1831T>C | p.Trp611Arg | missense_variant | Exon 15 of 25 | 3 | ENSP00000430832.2 | |||
| TAF2 | ENST00000690144.1 | c.1945T>C | p.Trp649Arg | missense_variant | Exon 16 of 26 | ENSP00000510548.1 | ||||
| TAF2 | ENST00000685202.1 | n.1945T>C | non_coding_transcript_exon_variant | Exon 16 of 27 | ENSP00000509214.1 | |||||
| TAF2 | ENST00000685503.1 | n.*1337T>C | non_coding_transcript_exon_variant | Exon 16 of 26 | ENSP00000509198.1 | |||||
| TAF2 | ENST00000685663.1 | n.*1817T>C | non_coding_transcript_exon_variant | Exon 18 of 28 | ENSP00000508988.1 | |||||
| TAF2 | ENST00000685684.1 | n.*3412T>C | non_coding_transcript_exon_variant | Exon 15 of 25 | ENSP00000509441.1 | |||||
| TAF2 | ENST00000685824.1 | n.*1646T>C | non_coding_transcript_exon_variant | Exon 14 of 24 | ENSP00000510262.1 | |||||
| TAF2 | ENST00000685876.1 | n.*1663T>C | non_coding_transcript_exon_variant | Exon 17 of 27 | ENSP00000510493.1 | |||||
| TAF2 | ENST00000685993.1 | n.*1760T>C | non_coding_transcript_exon_variant | Exon 15 of 25 | ENSP00000510102.1 | |||||
| TAF2 | ENST00000686098.1 | n.*590T>C | non_coding_transcript_exon_variant | Exon 15 of 25 | ENSP00000509102.1 | |||||
| TAF2 | ENST00000688037.1 | n.*1364T>C | non_coding_transcript_exon_variant | Exon 13 of 23 | ENSP00000510169.1 | |||||
| TAF2 | ENST00000689164.1 | n.*590T>C | non_coding_transcript_exon_variant | Exon 14 of 24 | ENSP00000508729.1 | |||||
| TAF2 | ENST00000689919.1 | n.*1663T>C | non_coding_transcript_exon_variant | Exon 17 of 26 | ENSP00000510768.1 | |||||
| TAF2 | ENST00000690808.1 | n.*1181T>C | non_coding_transcript_exon_variant | Exon 16 of 26 | ENSP00000509791.1 | |||||
| TAF2 | ENST00000690922.1 | n.*357T>C | non_coding_transcript_exon_variant | Exon 16 of 26 | ENSP00000509498.1 | |||||
| TAF2 | ENST00000691847.1 | n.*1246T>C | non_coding_transcript_exon_variant | Exon 15 of 24 | ENSP00000509663.1 | |||||
| TAF2 | ENST00000691880.1 | n.*1601T>C | non_coding_transcript_exon_variant | Exon 15 of 25 | ENSP00000508515.1 | |||||
| TAF2 | ENST00000692518.1 | n.*1646T>C | non_coding_transcript_exon_variant | Exon 14 of 25 | ENSP00000508959.1 | |||||
| TAF2 | ENST00000692707.1 | n.*1813T>C | non_coding_transcript_exon_variant | Exon 18 of 28 | ENSP00000509024.1 | |||||
| TAF2 | ENST00000692916.1 | n.*1332T>C | non_coding_transcript_exon_variant | Exon 15 of 25 | ENSP00000509603.1 | |||||
| TAF2 | ENST00000685503.1 | n.*1337T>C | 3_prime_UTR_variant | Exon 16 of 26 | ENSP00000509198.1 | |||||
| TAF2 | ENST00000685663.1 | n.*1817T>C | 3_prime_UTR_variant | Exon 18 of 28 | ENSP00000508988.1 | |||||
| TAF2 | ENST00000685684.1 | n.*3412T>C | 3_prime_UTR_variant | Exon 15 of 25 | ENSP00000509441.1 | |||||
| TAF2 | ENST00000685824.1 | n.*1646T>C | 3_prime_UTR_variant | Exon 14 of 24 | ENSP00000510262.1 | |||||
| TAF2 | ENST00000685876.1 | n.*1663T>C | 3_prime_UTR_variant | Exon 17 of 27 | ENSP00000510493.1 | |||||
| TAF2 | ENST00000685993.1 | n.*1760T>C | 3_prime_UTR_variant | Exon 15 of 25 | ENSP00000510102.1 | |||||
| TAF2 | ENST00000686098.1 | n.*590T>C | 3_prime_UTR_variant | Exon 15 of 25 | ENSP00000509102.1 | |||||
| TAF2 | ENST00000688037.1 | n.*1364T>C | 3_prime_UTR_variant | Exon 13 of 23 | ENSP00000510169.1 | |||||
| TAF2 | ENST00000689164.1 | n.*590T>C | 3_prime_UTR_variant | Exon 14 of 24 | ENSP00000508729.1 | |||||
| TAF2 | ENST00000689919.1 | n.*1663T>C | 3_prime_UTR_variant | Exon 17 of 26 | ENSP00000510768.1 | |||||
| TAF2 | ENST00000690808.1 | n.*1181T>C | 3_prime_UTR_variant | Exon 16 of 26 | ENSP00000509791.1 | |||||
| TAF2 | ENST00000690922.1 | n.*357T>C | 3_prime_UTR_variant | Exon 16 of 26 | ENSP00000509498.1 | |||||
| TAF2 | ENST00000691847.1 | n.*1246T>C | 3_prime_UTR_variant | Exon 15 of 24 | ENSP00000509663.1 | |||||
| TAF2 | ENST00000691880.1 | n.*1601T>C | 3_prime_UTR_variant | Exon 15 of 25 | ENSP00000508515.1 | |||||
| TAF2 | ENST00000692518.1 | n.*1646T>C | 3_prime_UTR_variant | Exon 14 of 25 | ENSP00000508959.1 | |||||
| TAF2 | ENST00000692707.1 | n.*1813T>C | 3_prime_UTR_variant | Exon 18 of 28 | ENSP00000509024.1 | |||||
| TAF2 | ENST00000692916.1 | n.*1332T>C | 3_prime_UTR_variant | Exon 15 of 25 | ENSP00000509603.1 |
Frequencies
GnomAD3 genomes Cov.: 33
GnomAD3 genomes
Cov.:
33
GnomAD4 exome AF: 0.00000137 AC: 2AN: 1461860Hom.: 0 Cov.: 33 AF XY: 0.00000138 AC XY: 1AN XY: 727228 show subpopulations ⚠️ The allele balance in gnomAD version 4 Exomes is significantly skewed from the expected value of 0.5.
GnomAD4 exome
AF:
AC:
2
AN:
1461860
Hom.:
Cov.:
33
AF XY:
AC XY:
1
AN XY:
727228
show subpopulations
⚠️ The allele balance in gnomAD version 4 Exomes is significantly skewed from the expected value of 0.5.
African (AFR)
AF:
AC:
0
AN:
33480
American (AMR)
AF:
AC:
0
AN:
44724
Ashkenazi Jewish (ASJ)
AF:
AC:
0
AN:
26132
East Asian (EAS)
AF:
AC:
0
AN:
39686
South Asian (SAS)
AF:
AC:
0
AN:
86256
European-Finnish (FIN)
AF:
AC:
0
AN:
53420
Middle Eastern (MID)
AF:
AC:
0
AN:
5768
European-Non Finnish (NFE)
AF:
AC:
2
AN:
1112000
Other (OTH)
AF:
AC:
0
AN:
60394
⚠️ The allele balance in gnomAD4 Exomes is highly skewed from 0.5 (p-value = 0.000000), which strongly suggests a high chance of mosaicism in these individuals.
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.375
Heterozygous variant carriers
0
1
1
2
2
3
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Exome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome Cov.: 33
GnomAD4 genome
Cov.:
33
Alfa
AF:
Hom.:
ClinVar
Significance: Pathogenic
Submissions summary: Pathogenic:1
Revision: no assertion criteria provided
LINK: link
Submissions by phenotype
Microcephaly-thin corpus callosum-intellectual disability syndrome Pathogenic:1
Sep 21, 2011
OMIM
Significance:Pathogenic
Review Status:no assertion criteria provided
Collection Method:literature only
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Pathogenic
BayesDel_addAF
Pathogenic
D
BayesDel_noAF
Pathogenic
DANN
Uncertain
DEOGEN2
Uncertain
D
Eigen
Pathogenic
Eigen_PC
Pathogenic
FATHMM_MKL
Pathogenic
D
LIST_S2
Uncertain
D
M_CAP
Uncertain
D
MetaRNN
Pathogenic
D
MetaSVM
Uncertain
T
MutationAssessor
Pathogenic
M
PhyloP100
PrimateAI
Pathogenic
D
PROVEAN
Pathogenic
D
REVEL
Pathogenic
Sift
Pathogenic
D
Sift4G
Pathogenic
D
Polyphen
D
Vest4
MutPred
Gain of helix (P = 0.027);
MVP
MPC
ClinPred
D
GERP RS
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.